BR112023003792A2 - Derivados de sulfamoil ureia contendo porção alquil-oxacicloalquila e usos dos mesmos - Google Patents

Derivados de sulfamoil ureia contendo porção alquil-oxacicloalquila e usos dos mesmos

Info

Publication number
BR112023003792A2
BR112023003792A2 BR112023003792A BR112023003792A BR112023003792A2 BR 112023003792 A2 BR112023003792 A2 BR 112023003792A2 BR 112023003792 A BR112023003792 A BR 112023003792A BR 112023003792 A BR112023003792 A BR 112023003792A BR 112023003792 A2 BR112023003792 A2 BR 112023003792A2
Authority
BR
Brazil
Prior art keywords
oxacycloalkyl
motion
containing alkyl
urea derivatives
derivatives containing
Prior art date
Application number
BR112023003792A
Other languages
English (en)
Portuguese (pt)
Inventor
G Bock Mark
Harrison David
E Scanlon Jane
Original Assignee
Nodthera Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nodthera Ltd filed Critical Nodthera Ltd
Publication of BR112023003792A2 publication Critical patent/BR112023003792A2/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4151,2-Diazoles
    • A61K31/41551,2-Diazoles non condensed and containing further heterocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00Indexing scheme relating to specific properties of organic compounds
    • C07B2200/05Isotopically modified compounds, e.g. labelled
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00Indexing scheme relating to specific properties of organic compounds
    • C07B2200/07Optical isomers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurosurgery (AREA)
  • Oncology (AREA)
  • Neurology (AREA)
  • Pain & Pain Management (AREA)
  • Molecular Biology (AREA)
  • Rheumatology (AREA)
  • Communicable Diseases (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
BR112023003792A 2020-09-04 2021-09-03 Derivados de sulfamoil ureia contendo porção alquil-oxacicloalquila e usos dos mesmos BR112023003792A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US202063074521P 2020-09-04 2020-09-04
PCT/US2021/049001 WO2022051582A1 (en) 2020-09-04 2021-09-03 Sulphamoyl urea derivatives containing alkyl-oxacycloalkyl moiety and uses thereof

Publications (1)

Publication Number Publication Date
BR112023003792A2 true BR112023003792A2 (pt) 2023-03-28

Family

ID=77951864

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112023003792A BR112023003792A2 (pt) 2020-09-04 2021-09-03 Derivados de sulfamoil ureia contendo porção alquil-oxacicloalquila e usos dos mesmos

Country Status (12)

Country Link
US (1) US20240043410A1 (https=)
EP (1) EP4208459A1 (https=)
JP (1) JP2023540733A (https=)
KR (1) KR20230061505A (https=)
CN (1) CN116783184A (https=)
AR (1) AR123435A1 (https=)
AU (1) AU2021336518A1 (https=)
BR (1) BR112023003792A2 (https=)
CA (1) CA3191410A1 (https=)
IL (1) IL301055A (https=)
MX (1) MX2023002686A (https=)
WO (1) WO2022051582A1 (https=)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201721185D0 (en) 2017-12-18 2018-01-31 Nodthera Ltd Sulphonyl urea derivatives
PL3983387T3 (pl) 2019-06-12 2024-08-19 NodThera Limited Pochodne sulfonylomocznika i ich zastosowania
WO2025104268A1 (en) 2023-11-17 2025-05-22 NodThera Limited Forms of urea derivatives and related uses
WO2025104244A1 (en) * 2023-11-17 2025-05-22 NodThera Limited Methods of preparing urea derivatives
WO2025153532A1 (en) * 2024-01-16 2025-07-24 NodThera Limited Nlrp3 inhibitors and glp-1 agonists combination therapies

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4522811A (en) 1982-07-08 1985-06-11 Syntex (U.S.A.) Inc. Serial injection of muramyldipeptides and liposomes enhances the anti-infective activity of muramyldipeptides
US5763263A (en) 1995-11-27 1998-06-09 Dehlinger; Peter J. Method and apparatus for producing position addressable combinatorial libraries
PT1270565E (pt) 1997-01-29 2004-09-30 Pfizer Furano-2-sulfonamida 4-substituida e sua utilizacao na preparacao de derivados de sulfonilureia
SI3259253T1 (sl) * 2015-02-16 2020-07-31 The University Of Queensland Sulfonilsečnine in sorodne spojine ter njihova uporaba
ES2988798T3 (es) 2017-07-24 2024-11-21 Novartis Ag Compuestos y composiciones para el tratamiento de afecciones asociadas a la actividad de NLRP
GB201721185D0 (en) * 2017-12-18 2018-01-31 Nodthera Ltd Sulphonyl urea derivatives
KR20210053910A (ko) * 2018-08-15 2021-05-12 인플라좀 리미티드 신규한 설폰아마이드유레아 화합물

Also Published As

Publication number Publication date
JP2023540733A (ja) 2023-09-26
KR20230061505A (ko) 2023-05-08
WO2022051582A1 (en) 2022-03-10
MX2023002686A (es) 2023-04-03
IL301055A (en) 2023-05-01
AR123435A1 (es) 2022-11-30
EP4208459A1 (en) 2023-07-12
CA3191410A1 (en) 2022-03-10
CN116783184A (zh) 2023-09-19
US20240043410A1 (en) 2024-02-08
AU2021336518A1 (en) 2023-03-23
TW202229265A (zh) 2022-08-01

Similar Documents

Publication Publication Date Title
BR112023003792A2 (pt) Derivados de sulfamoil ureia contendo porção alquil-oxacicloalquila e usos dos mesmos
MX2020006399A (es) Derivados de sulfonil urea.
ZA202000425B (en) Selective inhibitors of nlrp3 inflammasome
PH12021550166A1 (en) Nlrp3 inflammasome inhibitors
ECSP21080740A (es) Inhibidores del inflamasoma nlrp3
WO2004071400A3 (en) Histone deacetylase inhibitors of novel benzamide derivatives with potent differentiation and anti-proliferation activity
EA201992152A1 (ru) Химические соединения
PE20240881A1 (es) Uso de un inhibidor de la ezh2 en la preparacion de farmacos para el tratamiento del linfoma de linfocitos t
EP3937929A1 (en) Charged ion channel blockers and methods for use
MX2023002547A (es) Compuestos novedosos como inhibidor de histona desacetilasa 6 y composicion farmaceutica que comprende los mismos.
WO2021091585A1 (en) Charged ion channel blockers and methods for use
JOP20220281A1 (ar) مركبات وتركيبات لتثبيط نشاط hif2 ألفا وطرق لاستخدامها
WO2020185881A1 (en) Charged ion channel blockers and methods for use
DOP2025000013A (es) Inhibidores de inflamasoma nlrp3
CL2021003034A1 (es) Métodos de tratamiento del síndrome de sjögren utilizando un inhibidor de la tirosina quinasa de bruton
MX2024014315A (es) Compuestos amido heteroaromaticos utiles en el tratamiento de enfermedades hepaticas
MX2022015524A (es) Formas cristalinas del acido {2-[3-ciclohexil-3-(trans-4-propoxi-c iclohexil)-ureido]-tiazol-5-ilsulfanil}-acetico y uso de las mismas.
CO2025014389A2 (es) Derivados de amida para inhibir nlrp3 y usos de estos
MX2025011886A (es) Derivados biciclicos semisaturados y usos relacionados
MX2025003934A (es) Métodos para preparar derivados de carbamato
CO2025007987A2 (es) Derivados de tiadiazol como inhibidores de la sintasa de gmp-amp cíclico y usos de los mismos
EA202192057A1 (ru) Карбаматные производные и их применение
JP7752870B2 (ja) 発毛を誘導するためのイタコネートおよびその誘導体/類似体の使用
BR112023002082A2 (pt) Síntese de derivados de imipridona e sua avaliação para sua atividade anticancerígena
MX2024008477A (es) Derivados biciclicos de ftalazina-1(2h)-ona y usos relacionados.